Alessandra Geremia
Academic Clinical Lecturer
I graduated in Medicine and Surgery and trained as a Gastroenterologist in the "Tor Vergata" University of Rome, Italy. During my clinical training I participated in clinical studies on the management of inflammatory bowel disease (IBD) patients. I then worked as a research fellow at the Wellcome Trust Centre for Human Genetics in Oxford and took part in genetic association studies on IBD.
My DPhil project focuses on the role of the IL23/IL17 pathway in inflammatory bowel disease. In particular, I am studying the effect of IL23 on adaptive and innate cells isolated from the blood and intestine of patients with IBD and non inflammatory controls
Recent publications
-
Host-microbial crosstalk in the pathogenesis of inflammation and cancer in primary sclerosing cholangitis
Conference paper
(2019), Journal of crohn's and colitis
-
Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis
Conference paper
(2019), Journal of crohn's and colitis
-
LYMPHOCYTE ACTIVATION GENE (LAG)-3 ON T CELLS IS A POTENTIAL THERAPEUTIC TARGET IN ULCERATIVE COLITIS
Conference paper
Slevin S. et al, (2019), Gastroenterology, 156, S872 - S873
-
Host-microbial crosstalk in the pathogenesis of colon cancer in Primary sclerosing cholangitis
Conference paper
(2018), Journal of crohn's and colitis
-
The role of genetics in Crohn's disease: how could it influence future therapies?
Journal article
Geremia A. and Satsangi J., (2018), Expert rev gastroenterol hepatol, 12, 1075 - 1077